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Sulfhydryl oxidaseAutographa californica multiple nucleopolyhedrovirus (AcMNPV) ac92 is a core gene encoding a protein
associated with occlusion derived virus (ODV), binds human P53 and also has ﬂavin adenine dinucleotide
linked sulfhydryl oxidase activity but its role in the virus life cycle is not known. To determine ac92 function a
deletion virus (vAc92KO) was generated and transfected Sf9 cells revealed that vAc92KO infection was restricted
primarily to single cells and budded virus (BV) titer was reduced over 99.99%. However, viral DNA replication
was unaffected and development of occlusion bodies in vAc92KO-transfected cells evidenced progression to
very late phases of viral infection. AC92 localized to both the cytoplasm and nucleus, and was also associated
with BV as well as ODV. In BV AC92 was detected in BV envelope and nucleocapsid fractions. Finally it was
shown that the ac92 homologue from the Group II alphabaculovirus Mamestra conﬁgurata NPVmaco96 could
only partially rescue vAc92KO.
Crown Copyright © 2010 Published by Elsevier Inc. All rights reserved.Introduction
Baculoviridae comprises a large and diverse group of viruses which
are pathogens of insects that are known to infect Lepidoptera, Hy-
menoptera and Diptera. During the typical biphasic infection cycle,
two structurally and functionally distinct enveloped virion pheno-
types are produced: occlusion derived virus (ODV) and budded virus
(BV) (Miller, 1997; Rohrmann, 2008). ODVs are occluded in the
nucleus in a protein matrix that forms occlusion bodies which are
required for interhost transmission of the virus. After release from
occlusion bodies in the alkaline environment of the midgut lumen,
ODVs initiate primary infection of host larvae. BVs are produced when
nucleocapsids bud through the plasma membrane of the midgut
epithelial cells or other tissues to initiate secondary infections within
the infected animal.
Autographa californica multiple nucleopolyhedrovirus (AcMNPV),
the archetype species of the alphabaculoviruses of the Baculoviridae,
has a circular double-stranded DNA genome of approximately
134 kilobase pair (kbp) that contains 154 predicted open reading
frames (ORFs) (Ayres et al., 1994). One of the ORFs ac92 encodes a
core gene conserved in all sequenced baculoviruses. It has been found
that AC92 forms a complex with human tumor suppressor P53 andntre, Agriculture andAgri-Food
ax: +1 250 494 6415.
eilmann).
.
, University of Massachusetts
ster, MA 01605, USA.
10 Published by Elsevier Inc. All rigenhances P53-mediated apoptosis (Prikhod'ko et al., 1999). AC92
and its homologues have been identiﬁed as structural components of
ODV in multiple viruses by proteomic approaches (Braunagel et al.,
2003; Deng et al., 2007; Perera et al., 2007). Very recently, an in vitro
study demonstrated that AC92 has a ﬂavin adenine dinucleotide
(FAD) linked sulfhydryl oxidase activity (Long et al., 2009). It was
suggested that the sulfhydryl oxidase may be required for regulating
the redox state of replication factors or may be required for disul-
phide bonds in structural proteins. However, the role of AC92 in the
AcMNPV infection cycle is not yet known. Previous attempts to
inactivate ac92 by an insertion of lacZ were unsuccessful which
suggests that ac92 is essential for the viral infection (Prikhod'ko et al.,
1999).
In this study, a knockout mutant was used to show that deletion of
ac92 resulted in nearly complete loss of BV production. This indicates
that ac92 is an essential gene and suggests that viral sulfhydryl
oxidase is critical for AcMNPV replication. This study also determined
AC92 localized to both the cytoplasm and nucleus as well as to BV and
ODV during infection. Evolutionary conservation of function was
investigated by repair of the ac92null virus with maco96, the ac92
homologue from Mamestra conﬁgurata NPV (MacoNPV).
Results
Construction of ac92null and repaired viruses
Using the AcMNPV bMON14272 bacmid, an ac92null bacmid was
constructed based on homologous recombination in Escherichia coli
(Fig. 1) (Lin et al., 2001; Stewart et al., 2005). To examine the effect ofhts reserved.
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Fig. 1. Schematic diagram of construction of the bacmids vAc92KO, vAc92KO-AC92HA and vAc92KO-MACO96HA. The ac92 ORF (WT locus) was partially deleted by replacement with a zeocin
gene resistance cassette (KO locus; ampliﬁed with primers 1290 and 1291) via homologous recombination in E. coli, to generate ac92null. The deletion of ac92was conﬁrmed using
the primer pairs 1292/1014 and 1239/1293; their relative positions are indicated. The lower part of the ﬁgure shows the genes inserted in the polyhedrin (polh) locus of ac92null by
Tn7-mediated transposition to generate vAc92KO, vAc92KO-AC92HA and vAc92KO-MACO96HA.
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the polyhedrin and gfp genes were inserted into the polyhedrin locus of
ac92null by transposition (vAc92KO, Fig. 1). To conﬁrm that any
phenotype observed was due to the loss of ac92 a rescue virus
(vAc92KO-AC92HA) was generated, in which ac92 driven by its predicted
native late promoter with an HA epitope at the C-terminus was
inserted into the polyhedrin locus of ac92null bacmid. A third virus was
also generated to establish if the ac92 homologue from the group II
alphabaculovirus MacoNPV maco96 can rescue the ac92 deletion. The
maco96 driven by its predicted late promoter and tagged with HA
epitope sequence at the 3' end of the ORF was inserted into the
polyhedrin locus of ac92null to generate vAc92KO-MACO96HA (Fig. 1). The
use of maco96 to provides the means to determine if the function of
this core baculovirus protein was evolutionarily conserved. MACO96
has 50% identity to AC92 (Li et al., 2002) but retains the sulfhydryl
oxidase domain identiﬁed by Long et al. (2009). The wildtype
construct, vAcBac, which serves as a positive control, was constructed
by transposing polyhedrin and gfp gene into polyhedrin locus of
AcMNPV bacmid bMON14272 (Fig. 1).
Analysis of ac92 deletion and repair viruses in transfected Sf9 cells
To determine the effect of ac92 deletion on virus replication,
bacmidDNAs of vAc92KO, vAc92KO-AC92HA, vAc92KO-MACO96HA and vAcBac
were transfected into Sf9 cells. In all the constructs the expression
of gfp driven by the constitutive Orgyia pseudosugata MNPV ie1
promoter enables the monitoring of transfection by ﬂuorescence
microscopy (Fig. 2A). At 24 h post transfection (hpt), similar
percentages of GFP positive cells were observed from all four viruses,
indicating transfection efﬁciencies were comparable. As expected by
96 hpt the majority of Sf9 cells transfected with vAcBac showedinfection as evidenced by the visual detection of GFP expression. In
contrast, cells transfected with vAc92KO showed only a very limited
increase in the number of GFP expressing cells by 96 hpt compared to
vAcBac. vAc92KO-MACO96HA transfected cells showed a greater increase
in the number of GFP-positive cells at 96 hpt compared to vAc92KO, but
wasmuch lower compared to vAcBac. vAc92KO-AC92HA showed a similar
spread of infection to vAcBac which indicated that AC92HAwhich has
the C-terminal HA epitope tag could rescue the ac92 deletion. These
initial results therefore suggest that the deletion of ac92 reduces the
production of infectious BV.
Light microscopy analysis showed that occlusion bodies (OBs)
were produced by cells transfected with vAc92KO, vAc92KO-AC92HA,
vAc92KO-MACO96HA and vAcBac at 96 hpt. Signiﬁcantly fewer cells with
occlusion bodies were observed from cells transfected by vAc92KO and
vAc92KO-MACO96HA which would be consistent with the reduced
number of infected cells. However, the occlusion bodies produced
by all constructs exhibited similar appearance (Fig. 2B).
Virus growth curves
To conﬁrm that the deletion of ac92 led to a defect in BV produc-
tion and to determine the virus replication kinetics of these
constructs, quantitative polymerase chain reaction (qPCR) and 50%
tissue culture infective dosage (TCID50) were used to determine the
BV titres in the tissue culture supernatants. Sf9 cells were transfected
with vAc92KO, vAc92KO-AC92HA, vAc92KO-MACO96HA, vAcBac and BV
production at various times post-transfection were analyzed
(Fig. 3A). The qPCR analysis, which detects copies of viral genomes
regardless of infectivity, showed that no increase in vAc92KO and
vAc92KO-MACO96HA titers until between 48 and 72 hpt which was at
least 24 h later than vAcBac. In addition the levels of BV at 96 hpt of
Fig. 2. Viral replication analysis in Sf9 cells. (A) Fluorescence microscopy showing the progression of the infection in Sf9 cells transfected with vAc92KO, vAc92KO-AC92HA, vAc92KO-MACO96HA
and vAcBac at 24 and 96 hpt. (B) Light microscopy of Sf9 cells transfected with vAc92KO, vAc92KO-AC92HA, vAc92KO-MACO80HA and vAcBac at 96 hpt showing OB formation.
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lower than that obtained by vAcBac, respectively. vAc92KO-AC92HA
showed a slight reduction in BV compared to vAcBac but exhibited the
same temporal production of BV and reached similar levels as vAcBac
at 96 hpt.
To determine if infectious BVwas produced, the virus titers at 6 and
72 hpt were analyzed with TCID50 end-point dilution assays (EPDA,
Fig. 3B) and compared to the titres determined by qPCR. No infectious
BVwas detected from all constructs at 6 hpt. At 72 hpt very low titres of
infectious BV were detected from vAc92KO transfected cells (5.0×101
TCID50/ml). However, the titres at 72 hpt of vAc92KO-AC92HA and vAcBac
were 7.2×106 TCID50/ml and 2.6×107 TCID50/ml, respectively. The
titer of vAc92KO-MACO96HA reached 2.0×104 TCID50/ml at 72 hpi, three
logs higher than that of vAc92KO but three logs lower than that of
vAc92KO-AC92HA suggesting the MACO96HA could replace AC92 but the
functionality was not equivalent. The titration assays therefore
demonstrated that ac92 is required for the efﬁcient production of
infectious BV.
DNA replication assay of ac92 deletion and repair viruses in Sf9 cells
The reduction of BV production caused by the loss of ac92 could be
due to a reduction in viral DNA replication. Therefore to quantitatively
analyze the effect of ac92 deletion on viral DNA replication, Sf9 cells
were harvested at various times post-transfection and total DNA wasextracted and analyzed by qPCR (Fig. 4). The temporal proﬁles of DNA
replication were similar for all constructs but the levels obtained
varied. For vAcBac and vAc92KO-AC92HA DNA synthesis levels were
equivalent and continued to increase up to 72 hpt. For vAc92KO and
vAc92KO-MACO96HA the viral DNAs did not increase dramatically like
vAcBac which would agree with the reduced levels of BV production
and in turn the reduced production of secondary infections. At 96 hpt,
the DNA level of vAc92KO-MACO96HA showed half log increase compared
with that of 72 hpt, and was greater than the levels of vAc92KO,
indicating the occurrence of new infection which is consistent to the
higher production of infectious BV (Fig. 3B). Together these results
suggest that the deletion of ac92 does not affect the onset and level of
DNA replication.
Expression and cellular localization of AC92 during infection
To further understand the function of ac92 in the viral life cycle, it
is necessary to establish its temporal expression and cellular local-
ization. A time course analysis of AC92 expression in infected Sf9 cells
was performed using vAc92KO-AC92HA. Infected cells were collected at
various times post infection (pi), and the nuclear and cytoplasmic
fractions were separated. Western blot analysis showed that AC92
was detected from 18 to 72 hpi at the size of about 33 kDa and was
distributed in both the nucleus and the cytoplasm. From 18 to 24 hpi,
during peak BV production, AC92 localized to a greater extent in the
Fig. 3. Replication kinetics of Sf9 cells transfected with vAc92KO, vAc92KO-AC92HA,
vAc92KO-MACO96HA and vAcBac. (A) Virus growth curves determined by quantifying
the number of viral genomes using qPCR analysis of supernatants collected from Sf9
cells transfected with vAc92KO, vAc92KO-AC92HA, vAc92KO-MACO92HA and vAcBac at the
designated time points. (B) Infectious virus titers at 6, 72 hpt determined by TCID50
EPDA. Each data point represents the average titer derived from two independent
assays.
Fig. 5. Expression and cellular localization of AC92HA and MACO96HA. Sf9 cells were
infected with vAc92KO-AC92HA or (B) transfected with vAc92KO-MACO96HA bacmid DNA.
Cells were harvested and separated into the cytoplasmic (C) and nuclear (N) fractions.
Fractions were separated by SDS-PAGE and probed with anti-HA to detect HA-tagged
AC92 and MACO96. Duplicate blots were also probed with anti-IE1 and anti-GP64
monoclonal antibodies to detect IE0 and IE1, and GP64, respectively to conﬁrm
separation of nuclear and cytoplasmic fractions. Bound antibody was detected by with
peroxidase-linked secondary antibody and visualized by chemiluminescence.
41Y. Nie et al. / Virology 409 (2011) 38–45cytoplasm (Fig. 5A). As a control to show the proper fractionation
process, the same samples were probed with an IE1 antibody and a
GP64 antibody. The presence of IE1 and GP64 exclusively in the
nuclear and cytoplasmic fractions, respectively, conﬁrmed the cell
fractionation was successful.
The cellular localization of AC92 was also analyzed by immuno-
ﬂuorescence confocal microscopy. In uninfected Sf9, no ﬂuorescence
was detected demonstrating the speciﬁcity of HA antibody (Fig. 6A).
In cells infected by vAc92KO-AC92HA, at 24 hpi AC92was detected evenly
throughout the cytoplasm, where in the nucleus it was distributed
predominately at the periphery of the virogenic stroma (stained blueFig. 4. Quantitative real-time PCR analysis of viral DNA replication. Sf9 cells (1.0×106)
were transfected with 1.0 μg of vAc92KO, vAc92KO-AC92HA, vAc92KO-MACO92HA and vAcBac
DNA. At various hpt, total DNA was extracted and viral DNA was quantiﬁed by qPCR.
Each time point represents the average of two independent replication assays.by DAPI) which is also know as the ring zone. By 48 hpi, the AC92
ﬂuorescence signal showed even greater intensity at the periphery of
the virogenic stroma and increased levels could also be detected
within the virogenic stroma. At 48 hpi the cytoplasmic AC92 remained
relatively evenly distributed. The AC92 localization pattern from
immunoﬂuorescence was consistent with the results obtained from
the fractionation and Western blot analyses.
Expression and cellular localization of MACO96 in Sf9 cells
To determine if the expression and distribution of MACO96
in Sf9 cells resembles that of AC92, Sf9 cells were transfected by
vAc92KO-MACO96HA and collected at various times post transfection.
Transfection instead of infection was used as the titres obtained from
Fig. 6. Localization of AC92HA by immunoﬂuorescence confocal microscopy. (A) Sf9 cells were infected with vAc92KO-AC92HA or (B) transfected with vAc92KO-MACO962HA bacmid DNA.
At the times indicated cells were ﬁxed, probed with mouse monoclonal HA antibody to detect AC92HA or MACO96HA and bound antibody was detected by Alexa 635-conjugated
goat anti-mouse IgG (red) and visualized using confocal microscopy. Cells were also stained with DAPI to directly visualize nuclear DNA (blue).
Fig. 7. Analysis of AC92HA in puriﬁed and fractionated virions. BV and ODV were
puriﬁed using a sucrose gradient and the envelope and nucleocapsid fractions were
isolated as previously described (see Materials and methods). Fractions were analyzed
by SDS-PAGE and Western blotting and blots were probed with an anti-HA antibody to
detect AC92HA. To conﬁrm correct fractionation duplicate blots were probed with the
AcV5 monoclonal antibody to detect the BV envelope protein GP64, and anti-VP39 to
detect the nucleocapsid protein VP39. Bound antibody was detected by with
peroxidase-linked secondary antibody and visualized by chemiluminescence. NC,
nucleocapsid fraction; ENV, envelope fraction.
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presented similar distribution as AC92, detected from both the
cytoplasmic and the nuclear fractionation with a greater abundance
in the cytoplasm at 24 hpt and 48 hpt by Western blotting analysis
(Fig. 5B). However, when MACO96 localization was analyzed by
confocal immunoﬂuorescence microscopy, it was found that MACO96
had a similar even cytoplasmic distribution as that of AC92. However
within the nucleus MACO96was diffusely distributed at the periphery
of the virogenic stroma (Fig. 6B) rather than the more concentrated
localization observed for AC92 at both 24 and 48 hpi (Fig. 6A).
Differences in cellular localization may account for the inability of
MACO96 to fully rescue vAc92KO.
Western blot analysis of AC92 in puriﬁed BV and ODV
The previous reports have shown that AC92 is associatedwith ODV
(Braunagel et al., 2003). To investigate the localization of AC92 in
virion and if it is also a structural protein of BV, BV and ODV were
puriﬁed and analyzed by Western blot for the presence of AC92. The
results (Fig. 7) showed that AC92 could be detected in both BV and
ODV (lanes BV and ODV). The BV particles were also biochemically
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and ENV), and the Western blot analysis indicated that AC92 was
localized in both nucleocapsid and envelope fractions. As a control to
conﬁrm the efﬁciency of the fractionation, the known nucleocapsid
protein VP39 and the BV envelope-speciﬁc protein GP64 were also
analyzed. Both VP39 and GP64 were observed in the expected
fractions. These results showed that AC92 is associated with both BV
and ODV virions but surprisingly localizes to both the nucleocapsids
and envelope of BV.
Discussion
Ac92 has been found in all the baculovirus genomes sequenced so
far and is one of 31 core genes (Herniou et al., 2003; McCarthy and
Theilmann, 2008; Rohrmann, 2008) which suggests it performs a
common key function in the baculovirus life cycle. Previous studies
have shown that P33 binds the mammalian P53 protein and in
addition more recently it has been shown to have FAD-linked
sulfhydryl oxidase activity. In this study we generated an ac92
deletion virus, vAc92KO, to determine its role in the virus life cycle.
Previously proteomic analysis showed that AcMNPV AC92 is a
component of ODV (Braunagel et al., 2003). In this study, AC92 was
also shown to be a structural protein of BV where it localized to both
the nucleocapsid and envelope fraction (Fig. 7). Therefore, AC92 is
the fourteenth AcMNPV BV and ODV nucleocapsid protein identiﬁed,
along with P78/83 , VP1054, FP25, VLF-1, VP39, BV/ODV-C42, P87,
P24, 38 K, AC96, AC109, EXON0 (AC141) and AC142 (Braunagel et al.,
1999; Braunagel et al., 2001; Fang et al., 2007; Fang et al., 2009; Lu
and Carstens, 1992; McCarthy et al., 2008; Olszewski and Miller,
1997; Russell and Rohrmann, 1997; Russell et al., 1997; Thiem and
Miller, 1989;Wolgamot et al., 1993;Wu et al., 2008; Yang andMiller,
1998). Replication analysis showed that ac92 deletion does not
interfere the viral DNA replication but severely affects BV produc-
tion. The FAD-linked sulfhydryl oxidase activity of AC92 was
speculated to regulate the functions of the baculoviral single-
stranded DNA binding proteins (SSB) LEF-3 and DBP by affecting
the oxidized and reduced state of the proteins (Long et al., 2009).
However, deletion of ac92 did not have a major impact on viral DNA
replication. This result suggests that if AC92 does regulate SSB
proteins it is not required for viral DNA replication and is involved in
other processes.
vAc92KO was able to produce extremely low levels of infectious
BV (Fig. 3) even though AC92 was shown to be a potential structural
protein localized to both the nucleocapsid and envelope fractions of
BV (Fig. 7). This indicates that AC92 is not absolutely essential for the
assembly of nucleocapsids or for the egress and budding of nucleo-
capsids, but is required for the efﬁcient high level production of BV
since the level of production was dramatically reduced (1.66×108
TCID50/ml to 5. 0×101 TCID50/ml). It is also possible that the low titre
may be due to cell disintegration and release of ODV which has low
infectivity in tissue culture cells (Lynn, 2003). Sulfhydryl oxidases
have been identiﬁed in many families of DNA viruses (Hakim and
Fass, 2009) likely due to the need to generate cytosolic disulphide
bridges in locations where host enzymes do not normally exist. For
all baculoviruses assembly of virions occurs within the nucleus or
remnants of the nucleus, a non-traditional location for enzymes
involved in the formation of disulphide bridges. Similar to the results
of this study the African swine fever virus protein pB119L and the
vaccinia virus late protein E10R which have FAD-linked disulfhydryl
oxidase activity are also required for the production of virions.
Deletion of B119L decreases the number of viral particles by 90% and
also results in the production of aberrant virions (Rodriguez et al.,
2006). Vaccinia virus in addition to E10R encodes two additional
proteins that provide the complete pathway for disulphide bond
formation (Senkevich et al., 2002). Deletion of the E10R results in a
100 fold reduction of virus titres and electron microscopy showedaberrant virion morphogenesis. Mutation of the cysteines in the
conserved E10R C-X-X-C redox active site of the sulhydryl oxidase
domain also resulted in the reduction of virus titres which shows
that the enzyme activity is required for the virus production.
However, in this study substitution of AC92 with MACO96 which
contains the conserved enzyme domain identiﬁed by Long et al.
(2009) could only partially rescue vAc92KO. This would suggest that
supplying FAD-linked sulfhydryl oxidase activity is not all that is
required for AC92 function, however, enzymatic activity of MACO96
still needs to be conﬁrmed. As AC92 appears to be a structural
protein (Fig. 7) it is possible that the efﬁciency of assembly of nu-
cleocapsids is affected in vAc92KO and even though MACO96 may
supply the enzymatic activity it may not be able to interact correctly
with other viral or host proteins. Alternatively, reduced BV from the
maco96 repair may be a result of differential timing of MACO96
expression in the heterologous system. Cellular localization analysis
of AC92 and MACO96 showed that both proteins localized to both the
cytoplasm and the nucleus, but MACO96 had a more diffused pattern
compared with that of AC92. It is possible that the enrichment of
AC92 at the ring zone, not observed with MACO96, is required for the
high production of BV. In a concurrent study of an ac92 knockout
virus, Wu and Passarelli (2010) have shown by electron microscopy
that virogenic stroma, nucleocapsids and polyhedra formed correctly
but multiply enveloped ODV failed to form in the nuclear ring zone.
This observation would correspond with our confocal ﬂuorescence
microscopy results showing that AC92 accumulates in the ring zone at
late times post-infection.
In summary this study has shown that AC92 for which there are
homologues found in all knownbaculoviruses plays a key role in virion
morphogenesis and is essential for the successful baculovirus
infection. Determining which viral or host proteins are substrates for
AC92 should identify key aspects of baculovirus structure andprobably
also mechanisms of BV assembly and egress pathways.
Materials and methods
Viruses and cells
Spodoptera frugiperda Sf9 cells weremaintained in 10% fetal bovine
serum-supplemented TC100 medium at 27 °C. AcMNPV recombinant
bacmids were derived from the bacmid bMON14272 (Invitrogen Life
Technologies) and propagated in E. coli strain DH10B.
Construction of bMON 14272 ac92null and repaired bacmid
A zeocin resistance gene was ampliﬁed using primers 1290 (5'-
ACAAGTACAGCACGATCGTTTTGCTAGTCGCCATGATACCGCTGCT-
TATCTTTTTATCTTTTCGGATCTCTGCAGCAC-3') and 1291 (5'-TTATTG-
CAAATTTAACAATTTTTTGTATTCTCCCCATGTCATGCGTTCGTTC-
GAGGTCGACCCCCCTG-3') and p2ZeoKS as the template. These
primers contain 44 and 50 bp sequences homologous to the upstream
and downstream ﬂanking regions of ac92, respectively. In the ac92null
bacmid, 50 nt of the 3' end of ac92 was kept to preserve the putative
late motif for ac91 (TTAAG) and 12 nt of the 5' end was kept to
preserve the ac93 transcriptional start site. The internal 718 nt of ac92
were replaced by the zeocin resistance gene under control of the EM7
bacterial promoter as previously described (Stewart et al., 2005). The
PCR fragment of the zeocin resistance gene was gel puriﬁed and
electroporated into E. coli BW25113-pKD46 cells, which already con-
tained the AcMNPV bacmid bMON14272 DNA. The electroporated
cells were incubated at 37 °C for 4 h in 3 ml of SOCmedium and placed
onto agar medium containing 30 μg of zeocin per ml and 50 μg of
kanamycin per ml. These plates were incubated at 37 °C overnight,
and colonies resistant to zeocin and kanamycin were selected for
further conﬁrmation by PCR.
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been deleted from the ac92 locus of the AcMNPV bacmid genome
(Fig. 1). Primers 1292 (5'-AAATGGCCGTGATAAACT-3') and 1014 (5'-
CCGATATACTATGCCGATGAT T-3'), 1293 (5'- GTGGAGGTGTAGG-
TAACG-3') and 1239 (5'-CTGACCGACGCCGACCAA-3') were used to
detect the correct insertion of the zeocin gene cassette at the two
junctions of ac92 locus. Fragments of 436 bp and 320 bp which were
ampliﬁed with primers 1292/1014 and 1293/1239 from the ac92
deletion bacmid conﬁrmed the correct insertion of zeocin in the ac92
locus. One of the recombinant bacmids conﬁrmed by PCRwas selected
and named ac92null.
To tag AC92 with the inﬂuenza HA epitope (CYPYDVPDYASL) at
the C-terminus, ac92was ampliﬁed from bMON14272 AcBac with the
primers 1647 (5'-GCGCTGCAGTGATAACGTTGCTTCCGAA-3') and 1648
(5'-GCGTCTAGATTAGGCGTAGTCGGGCACGTCGTAGGGGTATTG-
CAAATTTAACAATTTTTTG-3') which places the HA tag sequence in
frame with the ac92 ORF at the 3' end. The ac92 homologue from
MacoNPV maco96 was ampliﬁed with primer 1649 (5'-GCGCTGCAG-
TAGCGTGTTAACACCGAA-3') and 1650 (5'-GCGTCTAGATTAGGCG-
TAGTCGGGCACGTCGTAGGGGTATTTTATTTCTAGTAACGATTT-3')
which places the HA tag sequence at the 3' end of the ORF. The ac92HA
and maco96HA PCR fragments contain their native promoters and
were digested with PstI and XbaI, cloned into the same sites of pFAcT-
GFP-Tnie1p(A) (Fig. 1) (Nie et al., 2009). In the resulting transfer
plasmids pFAcT-ac92HA and pFAcT-maco96HA, which have a Tricho-
plusia ni SNPV ie1 poly(A) downstream the ac92HA, maco96HA genes
and polyhedrin, gfp genes as markers, were conﬁrmed by restriction
enzyme digestion and sequencing. Both ac92HA, maco96HA were
introduced back into ac92null by Tn7-mediated transposition as
previously described by Luckow et al. (1993) by transformation with
transfer vectors pFAcT-GFP-Tnie1p(A), pFAcT-ac92HA and pFAcT-
maco96HA, the resulting viruses were named vAc92KO, vAc92KO-AC92HA,
vAc92KO-MACO96HA.Time course analysis of BV production and DNA replication
Sf9 cells (1.0×106 cells/35-mm-diameter well) were transfected
with 1.0 μg of each bacmid (vAc92KO, vAc92KO-AC92HA, vAc92KO-MACO96HA
or vAcBac). At various hours post transfection, supernatant containing
BV was harvested and cell debris was removed by centrifugation
(8000g for 5 min). Infected cells were washed once with phosphate-
buffered saline (PBS, 137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl,
pH7.4), scraped off with rubber policemen and pelleted by centrifu-
gation at 800g for 5 min. Supernatant was removed and the pellets
were stored at−80 °C until analysis. The BV production and viral DNA
replication analysis by qPCR were done as described by Nie et al.
(2009). BV titres at 6 and 72 hpt were also titrated in duplicate by end
point dilution in Sf9 cells with 96-well microtiter plates or by qPCR.Fractionation of cytoplasmic and nuclear fraction
Sf9 cells (1×106/35-mm-diameter well) were infected with
vAc92KO-AC92HA atMOI of 2 or transfectedwith 1 μg of vAc92KO-MACO96HA.
At 6, 12, 18, 24, 48, 72 hpi or hpt, cells were washed with PBS and
scraped off with a rubber policeman, pelleted by centrifugation at 800g
for 5 min. The pellets were gently resuspended in 60 μl of NP40-lysis
buffer (10 mM Tris, pH 7.9, 10 mM NaCl, 5 mM MgCl2, 1 mM
dithiothreitol, NP-40 0.5% (V/V)) and incubated on ice for 5 min.
Cytoplasmic and nuclear fractions were separated by centrifugation
at 1000g for 3 min. The nuclear pellets were resuspended in the same
volume of NP40-lysis buffer. Equal volume of 2× SDS protein sample
buffer (PSB, 0.25 M Tris–HCl, pH6.8, 4%SDS, 20% glycerol (V/V), 10%
2-mercaptoethanol, 0.05% bromophenol blue) was mixed with the
fractions for SDS-PAGE and Western blot analysis.Puriﬁcation of BV and ODV
Sf9 cells (2.0×106 /ml) were infected with vAc92KO-AC92HA with a
MOI of 0.1 in two spinner ﬂasks. Six days post infection, 80 ml of BV
supernatants and infected cells were harvested for BV and ODV
puriﬁcation. Puriﬁed BV was further separated to BV envelope and
nucleocapsids as previously described (Fang et al., 2007).
Western blot assay
Protein samples from Sf9 cell pellets and puriﬁed virions were
subjected to Western blot as described previously (Fang et al., 2007).
The antibodies used were: (i) mouse monoclonal anti-HA antibody
(HA.11, Covance), 1:1,000; (ii) mouse monoclonal OpMNPV VP39,
1:3,000; (iii) mouse monoclonal IE1 antibody (1: 5,000); (iv) mouse
monoclonal GP64 AcV5 antibody (1:5,000) (Hohmann and Faulkner,
1983; Pearson et al., 1988; Ross and Guarino, 1997).
Immunoﬂuorescence
Sf9 cells were infected with vAc92KO-AC92HA with a MOI of 2 or
transfected with vAc92KO-MACO96HA (1 μg per 1×106 cells). At 24 and 48
hpi or 48 hpt, the supernatant was removed and the cells were washed
once in PBS, followed by ﬁxation in 3.5% paraformaldehyde in PBS for
10 min. The ﬁxed cells were washed three times in PBS for 15 min,
followed by permeabilization in 0.15% Triton X-100 in PBS for 15 min.
The cells were then blocked for 60 min in blocking buffer (2% bovine
serum albumin in PBS), followed by 1 h incubation with mouse
monoclonal anti-HA antibody (1:200) (Covance, HA11). The cells were
washed three times for 10 min each time in blocking buffer, followed by
1 h incubationwith an Alexa 635-conjugated goat anti-mouse antibody
(1:500) (Molecular Probes). The cells were subsequently washed three
times for 10 min each time in PBS, followed by staining with 200 ng/ml
4', 6-diamidino-2-phenylindole (DAPI) (Sigma) and examined using a
Leica confocal Microscope.
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